WEIGHING RISKS AND BENEFITS OF DRUGS
Right now many public officials and newspaper editorial boards are debating whether the U.S. Food and Drug Administration is too lax in its oversight of drugs such as Vioxx. However, this New York Times story about an experimental Parkinson’s drug is a good reminder that some patients–especially those with serious health problems–are willing to accept significant risks in exchange for the promise of a potentially successful treatment.
Posted in: Health care
You must be logged in to post a comment.
Categories: Health care
American Thinker
» Mary Landrieu Takes Louisianans for a Ride
Blog Maverick
» Bing trying to get exclusive on Fox…SmartThe Other McCain
» Ho-hum: Another day, another 'Doug Hoffman, far-right extremist' spinMudville Gazette
» When the wind won't blowRedstate
» The Great Global Warming FraudMudville Gazette
» Bad Weather (Part Two)Mudville Gazette
» Bad Weather (Part I)
Add your opinion
Note from Michelle: This section is for comments from michellemalkin.com's community of registered readers. Please don't assume that I agree with or endorse any particular comment just because I let it stand. A reminder: Anyone who fails to comply with my terms of use may lose his or her posting privilege.